- Bristol-Myers earnings jump 27 percent, but stock falls Updated: Apr-28-15 3:17 pm
Higher sales of key new medicines and cost cuts helped lift drugmaker Bristol-Myers Squibb Co.'s first-quarter profit by nearly 27 percent.
- Bristol-Myers: 2 cancer drugs beat 1 against melanoma Updated: Apr-20-15 8:32 am
PHILADELPHIA - A study shows giving advanced melanoma patients two new Bristol-Myers drugs together held the deadly skin cancer at bay far longer than just one.
- Studies: Merck drug Keytruda effective against 3 cancers Updated: Apr-19-15 2:58 pm
TRENTON, New Jersey - One of the hot new cancer immunotherapy drugs, Merck & Co.'s Keytruda, strongly benefited patients with melanoma, lung cancer and mesothelioma, according to three studies presented Sunday at the American Association for Cancer Research conference in Philadelphia.